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Abstract
Background: Little is known about the subjective experience of breast cancer survivors after primary treatment.
However, these experiences are important because they shape their communication about their illness in everyday
life, usage and acceptance of healthcare, and expectations of new generations of patients. The present study
investigated this topic by combining qualitative and quantitative methods.
Methods: Breast cancer survivors in Bavaria, Germany were mailed a questionnaire up to seven years after
enrolment into a randomised controlled clinical trial and start of their therapy. This enquired about their worst
experiences during the breast cancer episode, positive aspects of the illness and any advice they would give to
newly diagnosed patients. A category system for themes was systematically created and answers were categorised
by two independent raters. Frequencies of key categories were then quantitatively analysed using descriptive
statistics. In addition, local treating physicians gave their opinion on the response categories chosen by their
patients.
Results: 133 (80 %) of 166 eligible patients who survived up to seven years returned the questionnaire. The most
prominent worst experience reported by survivors was psychological distress (i.e. anxiety, uncertainty; prevalence
38 %) followed by chemotherapy (25 %), and cancer diagnosis (18 %). Positive aspects of the illness were reported by
48 % with the most frequent including change in life priorities (50 %) and social support (22 %). The most frequent
advice survivors gave was fighting spirit (i.e. think positive, never give up; prevalence 42 %). Overall, physicians’
estimates of the frequency of these responses corresponded well with survivors’ answers.
Conclusions: Although physicians’ understanding of breast cancer patients was good, psychological distress and
chemotherapy-related side effects were remembered as particularly burdensome by a substantial part of survivors.
On the one hand, patients’ quality of life needs to be assessed repeatedly during medical follow-up to identify such
specific complaints also including specific recommendations to the physician for targeted psychosocial and medical
support. On the other hand the advices and positive aspects of the disease, reported by the survivors, can be used
to promote positive ways of coping with the illness.
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intervention
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Background
During the last years there has been growing interest re-
garding survivorship in breast cancer patients. One rea-
son is the increasing number of long-term survivors due
to improved screening and earlier treatment. A bulk of
studies has investigated quality of life in long-term
breast cancer survivors [1–5]. Overall it has been shown
that patients recover from most impairments during the
first year of illness [6–9] resulting in a long-term quality
of life that is comparable to the general female popula-
tion in most dimensions [1, 5]. Nonetheless, some per-
sistent specific complaints have been identified in breast
cancer survivors, such as arm symptoms, reduced sexual
functioning, or fatigue [3, 5, 10]. Besides, fear of recur-
rence is often prevalent and negatively affects well-being
[1, 10, 11]. A systematic review [12] of ten studies on
breast cancer survivors’ quality of life concluded that
good quality of life more than five years after diagnosis
was associated with the absence of chemotherapy or co-
morbidities, high income, and sufficient levels of social
support. However, many breast cancer survivors also ex-
perienced persistent specific complaints, such as arm
symptoms or sexual problems. Furthermore, numerous
more recent studies investigated various therapeutic ap-
proaches (stress reduction, exercise, counselling, spirit-
ual therapy) for improvement of quality of life in
randomised controlled trials [13–16].
These studies investigating long-term quality of life of
cancer survivors predominantly use standardised mea-
sures. To date, there exists no established questionnaire
that focuses specifically on the quality of life of survi-
vors. Therefore, most studies use instruments initially
developed for monitoring the course of diagnosis and
treatment, such as EORTC QLQ-C30 [17] or FACT-G
[18]. Although these instruments have their merits, it is
possible that they omit aspects of the cancer experience
that are important for survivors. Qualitative research is
one way to resolve this, as this allows us to explore the
survivor perspective and elicit a wider spectrum of an-
swers than closed-ended quality of life questions. Thus
issues can be detected that are omitted from standar-
dised questionnaires [19]. This may elicit new hypoth-
eses that can be analysed quantitatively. A good example
of this approach is the study by Lauver et al. [20] that
combined quantitative and qualitative measures to ex-
plore stressors after the end of primary therapies. By
using open-ended qualitative questions they identified
“dealing with uncertainties” as a stressor which would
have been otherwise overlooked.
Another relatively unexplored field is cancer survi-
vors’ personal evaluation of their illness course [21].
The meaning of the cancer experience to 58 long-
term survivors was investigated by Foley et al. [22]
using interviews more than five years post-diagnosis.
They demonstrated that most survivors reported ei-
ther little impact of cancer or even a positive long-
term influence on their lives, such as more inner
strength and a greater appreciation of life. This kind
of personal growth was associated with a better qual-
ity of life.
The starting point of this research was the patient per-
spective which is communicated in their everyday life to
family, friends, other patients, and physicians and might
influence women’s attitude toward the illness as well as
their use and acceptance of health services, support ser-
vices and alternative therapies. More specifically, the aim
of the present study was to examine the recollections of
breast cancer survivors seven years after diagnosis re-
garding their (1) worst experiences during the illness, (2)
potential positive aspects of the disease, and (3) the ad-
vice they would give to fellow patients. Another aim was
to investigate if these responses of patients correspond
with the opinion of their physicians regarding breast
cancer survivors’ worst and most positive experiences
and advices (4).
Methods
Sample
The study sample consisted of 200 female primary breast
cancer patients who had participated in a randomised
controlled clinical trial investigating the use of standar-
dised quality of life diagnostics and related therapies to
improve patients’ subjective recovery [23]. All partici-
pants had been surgically treated between 2004 and
2006 in one of five participating certified breast cancer
centres in Bavaria, Germany. To achieve high external
validity, the trial inclusion criteria had no restrictions re-
garding disease stage or age [24]. Details about the the-
oretical background, method, and results of this
complex intervention have been previously described
[23, 25–27].
Follow-up of survivors was conducted up to seven years
after breast cancer diagnosis in August and December
2012 (mean time since surgery 84 months; range 73–93
months). The term “survivor” is here used as five year sur-
vival of the cancer diagnosis, a criterion commonly ac-
cepted in cancer statistics [28, 29]. Therefore we supposed
that the chosen time point for follow-up was adequate to
investigate the perspective of “real” long-term survivors.
Design
A cross-sectional design was used for the present study.
This study constitutes Part IV (long-term implementa-
tion) of a large scale complex intervention project [30]
on the routine use of quality of life data in oncological
practice. Part I [26], II [27], and III [23] have already
been published. Ethical approval had been obtained from
the local university ethics committee (University of
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Regensburg, 03/197) and patients had given their in-
formed consent. In August 2012 all eligible women were
mailed a package of questionnaires supplemented by a
stamped return envelope and a cover letter informing
them about content and aims of the study. Patients who
did not respond within six weeks received one reminder
by telephone. Those who could not be contacted by
phone were mailed a reminder with the questionnaire
package [31]. There were no financial or other incentives
to respond.
Measures/instruments
Demographic and clinical variables
In this survey the following data were collected: age,
marital status, number of children, education level, and
employment status. Prognostic stage, type of surgical
procedure, and adjuvant/ neo-adjuvant therapy were ob-
tained from the original record of the randomised trial.
Qualitative questionnaire
The survivor questionnaire consisted of one page with
three qualitative, open-ended questions:
(1)“Which was the worst experience regarding your
cancer disease?”
(2)“Have there also been positive aspects according to
the illness?”
(3)“Which advice would you give newly diagnosed
breast cancer patients to cope with the disease?”
This questionnaire had been tested beforehand in a
pilot survey with breast cancer survivors who were not
part of the randomised trial cohort and thus did not take
part in the present survivorship study. Twelve women
with an earlier diagnosis of breast cancer participated in
the pilot study (mean time since diagnosis: 55.5 months,
range 11–84 months) with a mean age of 58 years (s.d. ±
7.5, range 45–69 years). Pilot participants evaluated the
qualitative questions as clearly formulated and easy to
understand. No woman perceived the content of the
qualitative questionnaire as unpleasant. Only one partici-
pant noted that the question asking for an advice for
newly diagnosed patients was difficult to answer. Over-
all, the qualitative questionnaire was highly accepted and
revealed useful insights into their illness so there was no
need for modification.
Developing a category system for qualitative answers
To analyse the qualitative data, categories were gener-
ated by inductive analysis encompassing all prominent
and relevant issues regarding the worst and positive ex-
periences and advice for fellow patients (see Fig. 1). Be-
cause little is known about the investigated research
field, candidate themes were derived from the data
instead of using a predefined category system [32]. This
was done independently by two investigators. Consensus
was reached by discussion.
To quantify the proportion of responders mention-
ing each finding, answers were transferred to an elec-
tronic database (Microsoft Access 2010). In the first
step, data were inspected using two different strat-
egies: (1) using a word-by-word analysis, frequency of
each word individually was counted using a computer
program. Through this, issues which were commonly
Fig. 1 Sequence of each step in the qualitative data analysis process
in the survivor study
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addressed by participants could be objectively identi-
fied, based on “Linguistic Inquiry and Word Count”
(LIWC) by Pennebaker et al. [33]); (2) using a more
holistic approach, the answers from all participants
were read to become familiar with the data and their
context. On the basis of (1) and (2) the most promin-
ent issues in women’s answers were identified and
transferred to a preliminary category system, consider-
ing the following criteria: each category should be
broad enough to include as much information as pos-
sible, so that a reasonable picture of women’s answers
could be given. At the same time categories were de-
signed to be as specific as possible, to include mean-
ingful information regarding content of the data.
Furthermore, categories were clearly circumscribed
and mutually exclusive so that data could be only
assigned to one category.
The final category system contained 11 different cat-
egories for worst experience, 6 categories for positive as-
pects and 13 categories for advice for fellow patients (see
Table 1). To facilitate the practical use of this coding
system, each category was illustrated with a short de-
scription and text examples that resembled but were not
identical to the patients’ original answers. Two raters (a
physician and a psychologist) were trained in this cat-
egory system and were then instructed to categorise all
patient responses independently [34]. Some answers
contained multiple statements belonging to more than
one category. Those had to be divided into single issues
and classified in different categories. Finally, both raters
met with the third independent expert (methodologist)
to discuss divergent ratings until consensus was achieved
[35].
Survey of coordinating practitioners
Following completion of data analysis of the patient sur-
vey, a survey was conducted with those physicians who
had taken care of the patients’ treatment and follow-up
during the randomised trial [23]. Thus, the physicians
were familiar with quality of life issues and would have
managed one or more patients who were participating in
the survivorship study. The aim of this survey was to
compare physicians’ opinions regarding worst and most
positive experiences of breast cancer survivors with the
survivors’ actual perspective. A total of 50 eligible physi-
cians were mailed a five-page questionnaire supple-
mented by a stamped return envelope and a letter
explaining the study aim. The questionnaire referred to
the three qualitative questions that were the focus of the
patient survey (worst experience, positive experience, ad-
vice to fellow patients). After presenting the five most
frequent categories from the patient survey for each of
the three qualitative questions, the physicians’ task was
to arrange the categories according to their expectation
of the survivors’ response frequency, from “1” (most
common answer) to “5” (less common answer). All the
categories and category descriptions were taken from
our analysis of the patient questionnaire data.
Statistical analysis
Agreement between the two raters of categories was
analysed using intercoder percent agreement and
Cohen’s kappa to account for random agreement. Re-
sponse categories were analysed quantitatively in a de-
scriptive manner and reported as frequencies and
proportions. For physicians’ ratings, means were calcu-
lated for each category as well as the percentage of each
category ranked as number “1”. All data were analysed
using SPSS software version 20.
Results
Participant characteristics
Of the 200 patients enrolled into the randomised study,
three patients refused further participation and 31 had
died at the time of the present study. Thus, 166 patients
were eligible and 133 returned the questionnaire, a re-
sponse rate of 80 % (Fig. 2).
The mean age of participants at long-term follow-up
was 64.2 years (s.d. ± 10.8) and average interval since
surgery was 84.8 months (s.d. ± 5.6). Further demo-
graphic and medical characteristics of participants are
reported in Table 2.
Respondents (n = 133) did not differ from non-
respondents (n = 33) regarding age, time since surgery,
stage, type of surgery, or recurrence of cancer.
133 respondents answered the questionnaire package
including both the quantitative quality of life question-
naire (not reported in this paper) and the qualitative
questions. Eight respondents missed this latter set of
questions. Thus, qualitative analysis was based on 125
participating survivors.
Qualitative analyses of worst and positive experiences
and advice for fellow patients
Analysis of response length and word frequency
The length in words of participants’ responses was
analysed: Women gave the longest answers when asked
for positive aspects of their disease with a median of
10.0 words per answer (range 1–24 words), while re-
sponses describing the worst experience during cancer
disease were shortest with a median of 5.0 words per
answer (range 1–43 words). In between was advice for
fellow patients (word length median 6.5, range 1–43
words).
In order to identify the most common issues in partic-
ipants’ answers, frequency of each single word was
counted electronically. The three most frequent nouns
addressing worst experience were “anxiety” (n = 25),
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Table 1 Final category system used for the qualitative and quantitative analysis
Category Description Sample characteristic statements by the women
Worst experience
Psychological
distress
Anxiety or uncertainty about the course or outcome of the
illness.
“uncertainty according to the outcome of surgery”; “uncertainty
about the future”; “anxiety”; “fear of recurrence”; “fear of dying”
Chemotherapy Chemotherapy or related side-effects. “chemotherapy”; “loss of hair”; “to look at myself due to the loss
of hair” “port implantation for chemotherapy”
Cancer diagnosis The shock of receiving cancer diagnosis and the fact of being
a cancer patient.
“communication of the diagnosis by the gynaecologist”; “Cancer
itself! I have always lived a healthy life”; “that you have cancer
and can’t forget it”
Mastectomy Removal of the breast and the affected body image. “removal of the breast, loss of self-esteem regarding sexuality”;
“losing my breast or dying”; “disfigurement of the body, consider-
able restrictions in dressing”
Social burden Fear of family or other conflicts in partnership or family caused
by the illness.
“to have to be strong for my family”; “the fear of my twin sister
and my daughter”; “that my husband couldn’t get along with the
changes of my body, what I never had expected”; “to see, how
my husband was suffering”;
Additional
illnesses
Additional diseases like comorbidities or recurrence during or
after breast cancer.
“I had a recurrence”; “cancer disease was accompanied by atrial
fibrillations – bad health status for a long time”; “arm pain
because my right upper arm was disabled by a fracture”
Radiotherapy Radiotherapy with related side-effects. “loss of energy because of radiation”; “after radiotherapy I had a
pneumonia for nearly five years after treatment with cortisone”
Endocrine
therapy
Endocrine therapy with related side-effects. “endocrine therapy with all side effects”; “the obligation to take
pills continuously despite circulatory complaints”; “my bones,
probably affected by the intake of medication”
Nothing No worst experience.
Other ”pain”; “fatigue”; “that life will never be the same!”; “Everything
happened at once. Diagnosis, divorce, driving test, moving
house”
Positive aspects
Change in life
priorities
Change of one’s own priorities in life in terms of living life
more consciously and relaxed, or changes in lifestyle.
“I think, you live more intensively and consciously”; “I have
reconsidered my life, changed several things”; “I see a lot of
things more relaxed”; “I have learnt to take more care of myself,
to say ‘no’ more often that makes me proud”
Social support Support by family, friends, or colleagues as well as unexpected
help from others.
“the experience of intensive and also often unexpected support
and friendship”; “my friends never abandoned me”; “I experienced
a lot of attention, appreciation and support”; “I met wonderful
people”
Good course of
cancer
The good course and outcome of the illness. “tumour was very small”; “no metastases”; “disease was early
detected because of annual check-up”
Support by
physicians/
nurses
The good (medical) treatment by physicians or nurses. “the experience of caring physicians and nurses”; “advice and
reassurance”; “the good medical attendance”
Gratitude Being grateful to have survived. “I have developed a profound feeling of gratitude”; “that I’m still
alive”; “looking back on my life and thankfulness”; “regarding
every day as a gift from God”
Other “I could manage my disease very well”
Advice
Fighting spirit Think positive, fight, and never lose hope. “never give up and think positive all the time”; “always thinking
‘Yes, I can manage that!’”; “Never lose hope!”
Information Keep calm, get a second opinion, and inform yourself about
the illness.
“inform yourself about all treatment options”; “don’t believe just
one single physician”; “inform yourself intensively in the internet,
get a second opinion”
Confidence in
physicians
Trust your physician and follow his/ her instructions. “do everything the doctor says”; “confidence in physicians”;
“adherence to treatment”
Openness Confide in somebody and talk a lot about the illness. “positive conversations, share your experiences”; “talking a lot
about the illness”; ““don’t hide the disease”
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“chemotherapy” (n = 25), and “diagnosis” (n = 16). Asked
for positive aspects, women most frequently used words
like “life/ living” (n = 15), “illness” (n = 7), and “positive”
(n = 7). When giving advice for fellow patients, the most
frequent words were “positive” (n = 23), “illness” (n = 18),
and “physician/s” (n = 12).
Interrater agreement
The median interrater percent agreement between the
two raters was 98 % for categories regarding worst expe-
riences, 93 % for positive aspects, and 99 % for advice for
fellow patients. To account for random agreements
Cohen’s kappa was also calculated. The median kappa
Table 1 Final category system used for the qualitative and quantitative analysis (Continued)
No advice It is not possible to give any advice for fellow patients. “I can’t give any advice”; “none, every patient comes to terms
with it another way”
Business as
usual
Don’t think too much about the illness, live life in a normal
way.
“fade out disease of daily life, live for the moment”; “master
everyday life as usual, domestic work, sports, friends, theatre”;
“don’t think too much about disease, distract yourself, and remain
cheerful”
Cancer
screening
Have regular cancer screening. “go to the doctor in time”; “regular cancer screening”; “early
detection by screening”
Acceptance Accept the illness. “things you can’t change you have to accept”; “accepting disease”
Self-reflection Reconsider your life. “consider disease as a touchstone and if applicable as turning
point, which is not solely negative but also offers opportunities to
find oneself”; “attend to your own soul, find out, what makes you
happy”
Belief in God Strengthening in faith. “pray a lot”; “don’t lose courage, my trust in God helped me a lot”
Support group Visit a support group. “contact other patients or a support group”; “visit a support
group as soon as possible”
Secrecy Keep your illness as a secret. “Inform as few people as possible! Hardly anybody can help!”
Other “Go to rehab”; “to undergo surgery immediately”; “no
complementary medicine, take part in a trial”; “accept help”
Fig. 2 Patient recruitment in the survivor study. Breast cancer survivors, initially part of a randomised trial, enrolled onto long-term follow-up
respecting drop-outs. Response rate of eligible patients in the survivor study 80 %
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Table 2 Demographic and medical characteristics of patient participants (n = 133)
No. of patients % of patients
Age (Mean ± s.d. 64.2 ± 10.8, range 41–92)
<50 8 6
50–59 45 34
60–69 36 27
70–79 31 23
80+ 13 10
Months since surgery
(Mean ± s.d. 84.8 ± 5.6, range 74–96)
Marital status
Married 101 76
Unmarried 4 3
Divorced 14 11
Widowed 14 11
Children
Children 113 85
No children 10 8
Unknown 10 8
Employment status
Employed full time 20 15
Employed part time 27 20
Retired/ not employed 80 60
Unknown 4 3
Educational level
Did not finish school 2 2
Compulsory 61 46
Advanced vocational 56 50
University 10 8
Unknown 6 5
Cancer stage at diagnosis
UICC 0 2 2
UICC I 68 52
UICC II (II a and b) 39 29
UICC III (III a, b, c) 21 16
Unknown 3 2
Surgical procedure
Breast conserving therapy 106 80
Mastectomy 27 20
Treatment (first year after surgery)
Chemotherapy 94 71
Radiotherapy 118 89
Endocrine therapy 113 85
Anti-HER2 monoclonal antibody 11 8
Recurrent cancer 15 11
s.d. standard deviation
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was 0.83 for worst experiences (range 0.41–0.98), 0.75
for positive aspects (range 0.49–0.95), and 0.95 for advice
for fellow patients (range 0.58–1.00) (it should be men-
tioned that for all three categories the lowest kappa was
observed with respect to the response option “other”).
Worst experience regarding breast cancer
Of the 125 survivors answering the qualitative question-
naire, 118 (94 %) responded to the question asking for
their worst experience during breast cancer (Table 3). By
far the most prominent worst experience was psycho-
logical distress, reported by 38 %. The category included
answers like “uncertainty about the future”, “fear of
recurrence”, or “fear of dying”. This was followed by
chemotherapy with 25 % (e.g. “to look at myself due to
the loss of hair”, “port implantation for chemotherapy”),
and cancer diagnosis with 18 % (e.g. “communication of
the diagnosis by the gynaecologist”, “Cancer itself! I have
always lived a healthy life”). The other defined categor-
ies were mentioned by less than 10 % of respondents.
12 % of issues were categorised as other including “pain”
which was noted by only two survivors as one of their
worst experiences (Table 3). Further examples of an-
swers from individual patients are given in Table 1.
Positive aspects of cancer
When asked if there had been also positive aspects of the
disease, about half of the survivors affirmed this question
(positive aspects: “yes” 60/125 (48 %); “no”: 54/125
(43 %); “missing” 11/125 (9 %)). Of those 60, 58 women
gave written information about their most positive ex-
perience (Table 3). A change in life priorities was re-
ported by 50 %. For example a woman answered “I have
reconsidered my life, changed several things” and another
described “I have learnt to take more care of myself, to
say ‘no’ more often that makes me proud”. Furthermore
22 % of survivors mentioned the role of social support
by family, friends, and colleagues (e.g. “the experience of
intensive and also often unexpected friendship”, “my
friends never abandoned me”). 16 % named the good
course of cancer (e.g. “tumour was very small”, “no me-
tastases”) and 10 % emphasised (medical) support by
physicians and nurses (e.g. “the experience of caring phy-
sicians and nurses”, “the good medical attendance”). The
remaining categories gratitude and other were used by
less than 10 % (see Tables 1 and 3).
Advice for fellow patients
This question was answered by 110 out of 125
women (88 %, Table 3). By far the most frequent ad-
vice for newly diagnosed patients was fighting spirit
with 42 %. In this regard a woman recommended
“never give up and think positive all the time” and
another one advised “Never lose hope!”. Furthermore,
16 % of survivors suggested information, for example
“inform yourself intensively in the internet, get a sec-
ond opinion” or “don’t believe just one single phys-
ician”. Another 11 % advised confidence in physicians.
(e.g. “do everything the doctor says”). Other categories
were used by less than 10 % (see Tables 1 and 3).
Evaluation of physicians
Of the 50 physicians contacted for the survivor survey,
one was retired and could not be reached by mail. Of
the remaining 49 doctors, 29 participated in the survey
(59 %). Those had a mean age of 53.8 years (s.d. ± 9.0),
were predominantly female (62 %) and all but one
Table 3 Frequency of breast cancer survivors’ answers about
their worst experience during breast cancer, positive aspects of
the illness and advice for fellow patients
Worst experience (n = 118) No. of patients % of patients
Psychological distress 45 38
Chemotherapy 29 25
Cancer diagnosis 21 18
Mastectomy 9 8
Social burden 8 7
Additional illness 7 6
Radiotherapy 3 3
Endocrine therapy 3 3
Nothing 1 1
Other 14 12
Positive Aspects (n = 58) No. of patients % of patients
Change in life priorities 29 50
Social support 13 22
Good course of cancer 9 16
Support by physicians/ nurses 6 10
Gratitude 5 9
Other 3 5
Advice (n = 110) No. of patients % of patients
Fighting spirit 46 42
Information 17 16
Confidence in physicians 12 11
Openness 10 9
No advice 10 9
Business as usual 8 7
Cancer screening 7 6
Acceptance 6 6
Self-reflection 5 5
Belief in God 4 4
Support group 2 2
Discreteness 2 2
Other 9 8
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worked as gynecologist with length of professional ex-
perience in treating patients with breast cancer from 6
to 46 years (Median 23.5) (see Table 4). Four of the 29
participants did not fill in the questionnaire appropri-
ately so their answers could not be analysed.
Overall, physicians’ estimates of the frequency of
women’s experiences corresponded relatively well with
their patients’ actual answers (Table 5). Regarding
women’s worst experience during breast cancer, doctors
and survivors named the same three issues most fre-
quently (cancer diagnosis, chemotherapy, psychological
distress). However, physicians underestimated the role of
psychological distress. This was by far the most frequent
answer of survivors (38 %), but was rated as the most
common answer by only 16 % of physicians. Instead,
60 % of doctors thought that cancer diagnosis was the
worst experience for patients (true answer 18 %).
Regarding positive aspects of cancer disease, physicians
also showed a good correspondence with their patients,
naming the issues in nearly the same order as the survi-
vors (Table 5). They only underestimated the role of sup-
port by physicians and nurses. While 10 % of survivors
reported this issue as their most positive experience dur-
ing the illness, 52 % of doctors thought it would be the
rarest answer given by patients.
When asked which advice breast cancer survivors
might give to newly diagnosed patients, physicians
(44 %) and survivors (42 %) similarly named fighting
spirit most frequently. Seeking information about the ill-
ness was also frequently named by doctors (21 %) and
women (16 %), while the role of openness was overesti-
mated by physicians (28 %) compared with patients
(9 %).
Discussion
The subject of survivorship is of increasing interest due
to the improved methods of cancer screening and ther-
apy that prolong survival. The present study investigated
how breast cancer patients remembered their illness epi-
sode about seven years after therapy onset. We are
aware that such retrospective reports are vulnerable to
distortions, such as recall and hindsight bias [36], re-
framing [37], and response shift [38, 39]. Different fac-
tors may contribute to recall bias [40] such as mood
[41], the kind of material to be remembered (i.e. infor-
mation in great detail) [42], or personal characteristics
(i.e. optimism [43]). So, we deliberately bypassed the
issue of “objectivity” and memory distortions, instead fo-
cusing on subjective recollections because these are the
kinds of opinions and experiences that are communi-
cated by survivors and shape the perceived stereotypes
of breast cancer via their families, friends, and the
media. These stories and stereotypes will in turn influ-
ence future generations of patients [21].
To our knowledge this is the only study investigating
the perspective of breast cancer survivors regarding their
course of illness which is also supplemented by the per-
spective of their physicians. The methodology we have
used can act as a paradigm for others to investigate
these issues. Open-ended, qualitative surveys go well be-
yond standardised assessment of quality of life and elicit
new information. In contrast a recent study by Hollen et
al. [44] investigated the importance of quality of life is-
sues that are listed by breast cancer patients in general
without assessing their subjective experiences in their
course of treatment and recovery.
Before discussing our results, the strengths and limita-
tions of the present study should be considered. The
study population was well-defined due to patients’ par-
ticipation in an earlier randomised trial [23]. The re-
sponse rate was high given that the study was conducted
Table 4 Characteristics of participating physicians (n = 29)
No. of
physicians
% of
physicians
Age (Mean ± s.d. 53.8 ± 9.0,
range 35–72)
<40 1 4
40–49 8 29
50–59 12 43
60–69 6 21
70+ 1 4
Sex
Female 18 62
Male 11 38
Specialisation
Gynaecologist 28 97
General practitioner 1 3
Professional experience
Breast cancer patients per year
(Median 30.0, range 10–700)
<20 8 28
20–50 13 45
51–100 2 7
101–199 4 14
200+ 2 7
Years treating breast cancer patients
(Median 23.5, range 6–46)
<10 2 7
10–19 8 29
20–29 11 39
30–39 6 21
40+ 1 4
s.d. standard deviation
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more than six years after diagnosis (80 %). Further-
more, this investigation has high external validity (no
exclusion according to age, stage, or recurrence, par-
ticipants from both urban and rural areas). Further
strengths are the emergent rather than predefined
categories and the use of duplicate assessors to de-
fine the categories from the data.
However, there are also some limitations: First, we used
a mailed survey instead of semi-structured interviews or
focus group meetings. Therefore, most of the qualitative
answers were short and enquiry for further explanation
was not possible. The reason to choose this method any-
how was that our participants were already familiar with
the questionnaire method. A mailed survey has also the
advantage that there is less likelihood of social desirability
than in interviews, no potential influence of the inter-
viewer, and the accessibility of a larger sample of partici-
pants. Another limitation is the response rate of only 59 %
in the physician survey. It is possible that only those doc-
tors who have a particularly close relationship with their
patients participated, so that the observed patient-
physician agreement might be overestimated. Third, al-
though this study can claim external validity for breast
cancer patients in Germany, future studies need to con-
firm results in other countries and healthcare settings.
In qualitative research each category will contain a
range of different perspectives. In order to address this
problem we tried to be as objective and data-driven as
possible when analysing patients’ qualitative statements.
We therefore used word counting to identify objectively
the most frequent issues in participants’ answers. In
addition, two raters categorised the data independently.
Nonetheless, we are aware that there is never a sole
truth [45].
Keeping these pros and cons in mind, one key result is
that the major part of our breast cancer survivors re-
membered psychological distress (such as fear of recur-
rence or uncertainty about the future) as their worst
experience. A possible explanation might be the high
prevalence of fear of recurrence which has been shown
in long-term breast cancer survivors [11]. Thus, uncer-
tainty and fear are still relevant to survivors so that these
psychological complaints are also remembered as par-
ticularly burdensome during the illness. This informa-
tion is directly relevant to physicians, who should
anticipate psychological distress in their patients during
the whole follow-up period and encourage patients to
express their fears so that these can be discussed. Good
patient-physician communication may help to reduce
these fears and uncertainties and improve patient satis-
faction [46] in order to prevent chronic psychological
distress in long-term survivors [47].
In addition, chemotherapy was reported by one out of
four women as particularly burdensome during the ill-
ness. These medical side effects have been already shown
to be common psychosocial concerns in women with a
recent diagnosis of breast cancer [48] and also remain
one of the most burdensome experiences remembered
by long-term survivors. Specific complaints of individual
breast cancer patients need to get more attention during
the time of medical treatment and follow-up. One solu-
tion to this problem is the regular assessment of the pa-
tient’s quality of life. These results need to be
communicated to the physician with recommendations
for tailored treatment of reduced quality of life [26]. This
kind of intervention has been demonstrated to be effect-
ive for breast cancer patients during the first year of
medical follow-up [23].
Another interesting result is that somatic symptoms
seemed to play little or no role in the patients’ recollec-
tion of their illness. In particular, the concern over
“pain” widely debated in oncology was almost never
mentioned by patients in our survivor study. This infor-
mation might help newly diagnosed breast cancer pa-
tients by taking away some of their fears.
Apart from this about half of the participants also re-
ported positive effects related to the illness. This is not-
ably lower than the percentage found by Sears et al. [49]
with 83 % of breast cancer patients reporting at least
Table 5 Physicians’ estimates of patients’ most frequent
answers (n = 25)
Physicians’responses Patients’
responses
Worst experience Mean % %a
Cancer diagnosis 1.8 60 18
Chemotherapy 2.5 24 25
Psychological distress 2.9 16 38
Social burden 3.4 - 7
Mastectomy 4.1 - 8
Positive aspects Mean % %a
Change in life priorities 2.1 52 50
Social support 2.5 24 22
Good course of cancer 3.0 16 16
Gratitude 3.2 8 9
Support by physicians 4.1 - 10
Advice Mean % %a
Fighting spirit 2.2 44 42
Openness 2.3 28 9
Information 2.8 21 16
Confidence in physicians/ nurses 3.3 8 11
Business as usual 4.1 4 7
apercentages based on raw counts of patients’ most frequent answers
(multiple answers were possible, see Table 3); Mean =mean of ranks on a
scale of 1–5; %: percentage of physicians rating the category as “most
frequent answer” (response category “1” on a scale of 1–5)
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one benefit in their disease. An explanation for these di-
vergent results might be that Sears et al. surveyed re-
cently diagnosed women whereas the present study
focused on the perspective of long-term survivors. Per-
haps finding benefit in the disease is especially important
during the time of diagnosis as a form of coping. But in
the long run it can be also maladaptive if expectations of
benefits are not realised [50]. Similarly, Foley et al. [22]
noticed that most cancer survivors experienced no im-
pact of the disease on their lives.
Of those women in our sample who reported positive
aspects most emphasised a change in life priorities. This
is closely related to the concept of ‘posttraumatic
growth’ - personally important changes as a result of a
life-threatening crisis - often described in relation to
cancer survivorship [51]. Similarly, a substantial number
of survivors in our sample mentioned that they are living
more intensively and consciously.
Furthermore, women evaluated the social support they
received during the illness as a positive aspect. Although
some survivors reported the social burden caused by
cancer (fear of family members, conflicts in partnership)
as their worst experience, a considerable number of the
women experienced positive social support by family,
friends, and colleagues. This seems to be an important
aspect of coping with the illness, as it has been demon-
strated that social support is a significant predictor for a
better long-term quality of life in breast cancer patients
[6]. Likewise, Sears et al. [49] identified the topic of so-
cial relationships as the most frequent benefit reported
by recently diagnosed breast cancer patients. Similarly,
social support was also relevant for survivors in the
present study but not as important as a change in life
priorities. Perhaps the meaning of positive experiences
changes during the course of the disease. Whereas social
support is most helpful in the acute phase of the illness
its role becomes less important during survivorship. In-
stead, personal changes are more relevant because they
are long-lasting and therefore can be still noticed as a
benefit in long-term survivors. This needs to be investi-
gated in future prospective studies.
Support by physicians and nurses was also stressed as a
positive aspect during cancer. Medical staff need to be
aware that they are an important aid for their patients in
coping with breast cancer. This information relates to
studies investigating patient-physician communication.
Those identified that breast cancer patients perceive a car-
ing attitude of the physician as more important than
information-giving [52]. Likewise, physician attentiveness
and empathy have been found to be associated with
greater patient satisfaction and reduced emotional distress
after the consultation in cancer patients [53]. In this sense
the present study supports the assumed high relevance of
patient-physician communication by demonstrating that a
positive relationship with physicians and nurses is still im-
portant in the recollection of long-term survivors.
Survivors who reported positive aspects of their dis-
ease were also more likely to give advice to fellow pa-
tients compared to those women who did not remember
any positive aspects. The vast majority recommended to
think positive, to fight, and to never give up. This kind
of fighting spirit has been found to be associated with
better psychological adjustment to advanced breast can-
cer [54, 55]. Additionally, previous studies identified a
positive relationship between trait optimism and well-
being in breast cancer patients during the course of
medical therapy [8, 56] and long-term follow-up [57].
The second most common advice was to inform oneself
intensively about the illness e.g. by using the internet or
by getting a second opinion. The specific information
needs of cancer patients have been described in a sys-
tematic review including 112 articles published between
1980 and 2003 [58]. Reasons why some cancer patients
do not want to get further information were qualitatively
analysed by Leydon et al. [59] conducting in depth inter-
views with 17 cancer patients. They identified three mo-
tivations: hope (keeping away fearful, contradictory, or
negative information to preserve hope), charity (con-
cerns about taking up too much time of the doctor to
the detriment of other patients), and faith (the doctor
knows best, medical knowledge is too complex to under-
stand). In agreement with the last explanation, some
women in our sample adopted a passive posture by
recommending confidence in physicians (do anything the
doctor says, faith in physicians and medical therapy).
The study also demonstrated good but not perfect cor-
respondence between physicians and patients. This is in
contrast to the bulk of previous studies [60, 61]. There
may be two explanations for this finding: (1) the meas-
urement method, asking for direct experiences instead
of standardised questionnaires and (2) the close relation-
ship of our physicians with their patients as a result of
regular follow-up, which might have been intensified by
the randomised trial [62]. Physicians realised the
affective dimension of the worst experience by choosing
cancer diagnosis first (60 %) and psychological distress
third (16 %). Patients had a similar opinion, although the
two issues were reversed in frequency. Patients and phy-
sicians agreed that psychological distress and cancer
diagnosis were particularly important elements of the
cancer experience in the follow-up. The important
lesson for physicians to learn is that distress caused by
fear of recurrence or uncertainty about the future prob-
ably plays a more important role in the follow-up phase
compared to the shock of diagnosis. So, in the medical
encounter patients’ fears need to be addressed repeat-
edly, also discussing prognosis and the risk of recur-
rence. Another finding was that doctors tended to
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underestimate the important role they played for their
patients: they need to be more aware of how much pa-
tients appreciate their medical and interpersonal support
as an important aid in coping with their disease.
Conclusions
This is the first study investigating the recollection of
breast cancer survivors regarding their course of illness
which is supplemented by the perspective of their physi-
cians. Results demonstrated that physicians had a good
overall understanding of the subjective experiences of
breast cancer patients. Most survivors remembered psy-
chological distress as their worst experience during
breast cancer, followed by chemotherapy. These issues
need to be considered even more in patient care. Physi-
cians should address patients’ fears repeatedly in the
medical encounter. Regular assessments of patients’
quality of life during medical follow-up can help to iden-
tify these specific complaints but should also include
recommendations for the physician for targeted psycho-
social and medical support. About half of the survivors
also reported positive aspects of the illness, such as a
change in life priorities. Their most frequent advice was
fighting spirit. These advices and positive aspects of the
disease should be further investigated to promote posi-
tive ways of coping with the illness.
Investigating the perspective of cancer survivors in this
way is important since subjective recollections of former
patients shape communication about the illness in every-
day life, usage and acceptance of health care and ultim-
ately, the expectations of new generations of patients.
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